Immunosuppression and oncogenic virus infections.
D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn / Q000276:immunology; D000956:Antigens, Viral; D004195:Disease Models, Animal; D016027:Heart Transplantation; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008213:Lymphocyte Activation; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000209:etiology / Q000276:immunology; D009374:Neoplasms, Experimental / Q000209:etiology / Q000276:immunology / Q000382:microbiology; D009858:Oncogenic Viruses / Q000276:immunology*; D011120:Polyomavirus; D011714:Pyrans / Q000627:therapeutic use; D013934:Thymectomy; D013950:Thymus Gland / Q000276:immunology; D013997:Time Factors; D014181:Transplantation Immunology; D014777:Virus Diseases / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D014779:Virus Replication
D000956:Antigens, Viral; D011714:Pyrans